5157-08-4

Usage

Uses

6-Methyl-2,3,4,5-tetrahydropyridazin-3-one (cas# 5157-08-4) is a useful research chemical.

InChI:InChI=1/C5H8N2O/c1-4-2-3-5(8)7-6-4/h2-3H2,1H3,(H,7,8)

Upstream product

• 1220703-70-7 5'-O-DMTr-rA(Bz)po(CNE)dT-3'-O-Lev 

Downstream Products

• 109-52-4 valeric acid 
• 13327-27-0 6-Methylpyridazin-3(2H)-on 
• 5788-47-6 6-Methylpyridazin-3-thion 
• 4702-76-5 N,N'-Bis-[1-p-tolyl-meth-(E)-ylidene]-hydrazine 
• 74819-18-4 6-methyl-4-(4-methylbenzyl)pyridazine-3(2H)-one 
• 3510-48-3 p-chlorobenzalazine 
• 74819-19-5 4-p-chlorophenylmethyl-6-methylpyridazin-3(2H)-one 
• 142300-90-1 2-{3-[Benzyl-(2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-amino]-propyl}-6-methyl-4,5-dihydro-2H-pyridazin-3-one 
• 588-68-1 benzaldehyde azine 
• 35991-02-7 4-phenylmethyl-6-methylpyridazin-3(2H)-one 
• 2299-73-2 C₆H₄OMeCHN₂CHC₆H₄OMe 
• 75256-52-9 4-p-methoxyphenylmethyl-6-methylpyridazin-3(2H)-one 
• 126775-18-6 4-(2-methoxybenzyl)-6-methylpyridazin-3(2H)-one 
• 1025154-57-7 4-(2-tert-butyl-benzyl)-6-methyl-2H-pyridazin-3-one 

Relevant academic research and scientific papers

Convergent solution phase synthesis of chimeric oligonucleotides by a 2+2 and 3+3 phosphoramidite strategy

A chimeric oligonucleotide tetramer and hexamer were synthesized by the phosphoramidite approach using a 2+2 and 3+3 strategy, respectively. The concept of convergent synthesis provides an efficient route toward the synthesis of longer chimeric oligonucle

Synthesis of diverse ethoxyformacetal oligomers. Toward libraries of metal-coordinating unnatural biopolymers

An expedient two-step iterative protocol for the solution-phase elaboration of ethoxyformacetal oligomers is described. A set of four O,S- thioformacetal donor monomers, with diverse chiral side-chains, were coupled using NIS/TfOH activation to afford three model tetramers.